141 related articles for article (PubMed ID: 19284806)
1. Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease.
Oba Y
Am J Manag Care; 2009 Feb; 15(2):97-104. PubMed ID: 19284806
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD.
Oba Y
Am J Manag Care; 2009 Apr; 15(4):226-32. PubMed ID: 19355795
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD.
Earnshaw SR; Wilson MR; Dalal AA; Chambers MG; Jhingran P; Stanford R; Mapel DW
Respir Med; 2009 Jan; 103(1):12-21. PubMed ID: 19010652
[TBL] [Abstract][Full Text] [Related]
4. Early assessment of the likely cost-effectiveness of a new technology: A Markov model with probabilistic sensitivity analysis of computer-assisted total knee replacement.
Dong H; Buxton M
Int J Technol Assess Health Care; 2006; 22(2):191-202. PubMed ID: 16571195
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity.
Sin DD; Golmohammadi K; Jacobs P
Am J Med; 2004 Mar; 116(5):325-31. PubMed ID: 14984818
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach.
Hass B; Lungershausen J; Hertel N; Poulsen Nautrup B; Kotowa W; Liedgens H
Eur J Health Econ; 2009 Jul; 10(3):309-21. PubMed ID: 19101743
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis.
Scheetz MH; Bolon MK; Postelnick M; Noskin GA; Lee TA
J Antimicrob Chemother; 2009 Apr; 63(4):816-25. PubMed ID: 19202150
[TBL] [Abstract][Full Text] [Related]
9. Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: comparison of costs.
Clini EM; Magni G; Crisafulli E; Viaggi S; Ambrosino N
Respiration; 2009; 77(1):44-50. PubMed ID: 18417954
[TBL] [Abstract][Full Text] [Related]
10. Cost utility of allogeneic stem cell transplantation with matched unrelated donor versus treatment with imatinib for adult patients with newly diagnosed chronic myeloid leukaemia.
Breitscheidel L
J Med Econ; 2008; 11(4):571-84. PubMed ID: 19450068
[TBL] [Abstract][Full Text] [Related]
11. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of health care costs for patients using home oxygen therapy or those in waiting lists].
Maquilón C; Chiong H; Bello S; Naranjo C; Lira P; Díaz M
Rev Med Chil; 2001 Dec; 129(12):1395-403. PubMed ID: 12080877
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese.
Xie F; Luo N; Blackhouse G; Goeree R; Lee HP
Int J Technol Assess Health Care; 2008; 24(1):87-95. PubMed ID: 18218173
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of sacral neuromodulation (SNM) with Interstim for fecal incontinence patients in Spain.
Brosa M; Muñoz-Duyos A; Navarro-Luna A; Rodriguez JM; Serrano D; Gisbert R; Dziekan K; Segú JL
Curr Med Res Opin; 2008 Mar; 24(3):907-18. PubMed ID: 18279582
[TBL] [Abstract][Full Text] [Related]
15. A comparison of health-care costs in patients with chronic obstructive pulmonary disease using lightweight portable oxygen systems versus traditional compressed-oxygen systems.
Mapel DW; Robinson SB; Lydick E
Respir Care; 2008 Sep; 53(9):1169-75. PubMed ID: 18718034
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD.
Najafzadeh M; Marra CA; Sadatsafavi M; Aaron SD; Sullivan SD; Vandemheen KL; Jones PW; Fitzgerald JM
Thorax; 2008 Nov; 63(11):962-7. PubMed ID: 18621985
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada.
Wagner M; Goetghebeur M; Merikle E; Pandya A; Chu P; Taylor DC
Can J Clin Pharmacol; 2009; 16(2):e331-45. PubMed ID: 19531812
[TBL] [Abstract][Full Text] [Related]
18. Heart failure disease management programs: a cost-effectiveness analysis.
Chan DC; Heidenreich PA; Weinstein MC; Fonarow GC
Am Heart J; 2008 Feb; 155(2):332-8. PubMed ID: 18215605
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence.
Siddiqui NY; Amundsen CL; Visco AG; Myers ER; Wu JM
J Urol; 2009 Dec; 182(6):2799-804. PubMed ID: 19837427
[TBL] [Abstract][Full Text] [Related]
20. Long-term cost-effectiveness of disease management in systolic heart failure.
Miller G; Randolph S; Forkner E; Smith B; Galbreath AD
Med Decis Making; 2009; 29(3):325-33. PubMed ID: 19147835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
